NO880520L - Fremgangsmaate for fremstilling av et cholestyraminpreparat - Google Patents

Fremgangsmaate for fremstilling av et cholestyraminpreparat

Info

Publication number
NO880520L
NO880520L NO880520A NO880520A NO880520L NO 880520 L NO880520 L NO 880520L NO 880520 A NO880520 A NO 880520A NO 880520 A NO880520 A NO 880520A NO 880520 L NO880520 L NO 880520L
Authority
NO
Norway
Prior art keywords
preparing
procedure
cholestyramine
preparation
cholestyramine preparation
Prior art date
Application number
NO880520A
Other languages
English (en)
Norwegian (no)
Other versions
NO880520D0 (no
Inventor
Gary J Schulz
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of NO880520D0 publication Critical patent/NO880520D0/no
Publication of NO880520L publication Critical patent/NO880520L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO880520A 1987-02-09 1988-02-05 Fremgangsmaate for fremstilling av et cholestyraminpreparat NO880520L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1247087A 1987-02-09 1987-02-09
US14069688A 1988-01-04 1988-01-04

Publications (2)

Publication Number Publication Date
NO880520D0 NO880520D0 (no) 1988-02-05
NO880520L true NO880520L (no) 1988-08-10

Family

ID=26683596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880520A NO880520L (no) 1987-02-09 1988-02-05 Fremgangsmaate for fremstilling av et cholestyraminpreparat

Country Status (6)

Country Link
EP (1) EP0278464A1 (da)
JP (1) JPS63290822A (da)
AU (1) AU610556B2 (da)
CA (1) CA1313135C (da)
DK (1) DK66988A (da)
NO (1) NO880520L (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85632A (en) * 1987-03-10 1991-08-16 Ciba Geigy Ag Hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
IL95574A (en) * 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
AU3812893A (en) * 1992-03-20 1993-10-21 Procter & Gamble Company, The Anion exchange resin compositions
US5942550A (en) * 1996-01-25 1999-08-24 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US6280717B1 (en) 1998-07-31 2001-08-28 Nikken Chemicals Co., Ltd. Cation exchange resin preparation
JP2007504239A (ja) * 2003-09-03 2007-03-01 マリンクロッド・インコーポレイテッド 顆粒状持続放出製剤およびその製造
PL3400944T3 (pl) 2010-11-04 2020-11-16 Albireo Ab Inhibitory ibat w leczeniu chorób wątroby
KR102560954B1 (ko) 2014-06-25 2023-07-31 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
ES2874669T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
EP3413875B1 (en) * 2016-02-09 2020-01-29 Albireo AB Cholestyramine pellets and methods for preparation thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
CN111032019B (zh) * 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
WO2019032027A1 (en) * 2017-08-09 2019-02-14 Albireo Ab CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP3802504B1 (en) 2018-06-05 2023-01-18 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
EP3810084A1 (en) 2018-06-20 2021-04-28 Albireo AB Pharmaceutical formulation of odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
DK3921028T3 (da) 2019-02-06 2023-01-23 Albireo Ab Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CN114761018B (zh) 2019-12-04 2025-12-02 阿尔比里奥公司 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
JP7696897B2 (ja) 2019-12-04 2025-06-23 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
ES2972045T3 (es) 2019-12-04 2024-06-10 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
DK4069360T3 (da) 2019-12-04 2024-02-26 Albireo Ab Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
CN116157389B (zh) 2020-08-03 2026-02-10 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
WO2022117778A1 (en) 2020-12-04 2022-06-09 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP4094753A1 (en) 2021-05-27 2022-11-30 Manfred Stangl Perforated cholestyramine capsule
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7311319A (da) * 1972-09-01 1974-03-05
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom

Also Published As

Publication number Publication date
EP0278464A1 (en) 1988-08-17
NO880520D0 (no) 1988-02-05
CA1313135C (en) 1993-01-26
JPS63290822A (ja) 1988-11-28
AU610556B2 (en) 1991-05-23
DK66988D0 (da) 1988-02-09
AU1126688A (en) 1988-08-11
DK66988A (da) 1988-08-10

Similar Documents

Publication Publication Date Title
NO880520L (no) Fremgangsmaate for fremstilling av et cholestyraminpreparat
NO173213C (no) Fremgangsmaate for fremstilling av et preparat omfattende et liposom
NO882103D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO881044D0 (no) Fremgangsmaate for fremstilling av en tiazepinforbindelse.
NO170516C (no) Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat
NO154821C (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
DK686187D0 (da) Veterinaert praeparat
NO169970C (no) Fremgangsmaate for fremstilling av et vaskepulver
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
NO934897L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
PT91631A (pt) A process for the preparation of cyclic graf-analogs ii
FI883916L (fi) Vesikovetteinen polymeerivalmiste
NO901232D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO870866L (no) FremgangsmŸte for fremstilling av et terapeutisk kombinasjonspreparat.
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
GB8719093D0 (en) Fibre preparation
NO172442C (no) Fremgangsmaate for fremstilling av en lavere alkenpolymer
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
IT8922190A0 (it) Procedimento per preparare n-fosfonometilglicina
NO171581C (no) Fremgangsmaate for fremstilling av et soppsmaksmiddel
NO902460L (no) Fremgangsmaate for fremstilling av en natriumpolyacrylatgel
NO170425C (no) Fremgangsmaate for fremstilling av en kopolymer
NO172095C (no) Framgangsmaate for framstilling av sondenaering
NO161779C (no) Fremgangsmaate for fremstilling av et antiforkjoelsespreparat.
NO882883D0 (no) Fremgangsmaate for fremstilling av et piperidinyl-cyklopentylheptensyre-derivat.